COSCIENS Biopharma (ET80) Financial Statements

0 Followers

COSCIENS Biopharma Financial Overview

COSCIENS Biopharma's market cap is currently €5.09M. The company's EPS TTM is €-15.42; its P/E ratio is -0.35; COSCIENS Biopharma is scheduled to report earnings on May 12, 2026, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Mar 25	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	$ 7.63M	$ 9.59M	$ 4.50M	$ 14.57M	$ 5.26M
Gross Profit	$ 2.69M	$ 4.73M	$ 4.28M	$ 8.56M	$ 5.17M
Operating Income	$ -10.62M	$ -14.02M	$ -18.01M	$ -15.38M	$ -8.67M
EBITDA	$ -9.41M	$ -13.49M	$ -17.99M	$ -15.36M	$ 2.85M
Net Income	$ -10.54M	$ -15.31M	$ -3.55M	$ 3.24M	$ 2.64M
Balance Sheet
Cash & Short-Term Investments	$ 7.29M	$ 16.39M	$ 34.02M	$ 50.61M	$ 65.30M
Total Assets	$ 21.39M	$ 35.07M	$ 37.02M	$ 56.03M	$ 80.10M
Total Debt	$ 2.15M	$ 2.31M	$ 3.39M	$ 3.86M	$ 4.16M
Net Debt	$ -5.15M	$ -14.08M	$ -4.94M	$ -46.75M	$ -65.14M
Total Liabilities	$ 17.56M	$ 21.91M	$ 18.82M	$ 20.25M	$ 27.12M
Stockholders' Equity	$ 3.84M	$ 13.16M	$ 18.20M	$ 35.78M	$ 52.99M
Cash Flow
Free Cash Flow	$ -9.34M	$ -15.73M	$ -17.14M	$ -13.69M	$ -9.22M
Operating Cash Flow	$ -8.62M	$ -14.57M	$ -2.62M	$ -13.68M	$ -8.58M
Investing Cash Flow	$ -466.02K	$ 25.08M	$ 528.00K	$ -12.00K	$ -658.00K
Financing Cash Flow	$ -414.12K	$ -588.00K	$ -151.00K	$ -118.00K	$ 51.04M

Currency in USD

COSCIENS Biopharma Earnings and Revenue History

Income Statement >

COSCIENS Biopharma Debt to Assets

Balance Sheet >

COSCIENS Biopharma Cash Flow

Cash Flow >

COSCIENS Biopharma Forecast EPS vs Actual EPS

Earnings >